PAR PHARMACEUTICAL COMPANIES, INC. 4
4 · PAR PHARMACEUTICAL COMPANIES, INC. · Filed Aug 4, 2010
Insider Transaction Report
Form 4
KENYON LAWRENCE A
EVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2010-08-02$26.90/sh−6,312$169,793→ 14,337 total
Footnotes (1)
- [F1]Surrender of shares in payment of tax withholding due as a result of the vesting of Restricted Stock granted in accordance with Rule 16b-3.